Mahamaya Lifesciences Ltd (544611) Stock Price & News

All values in INR	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	830.12M	800.52M	830.79M	830.79M
Cost of goods sold	718.46M	675.39M	676.74M	676.74M
Cost of revenue	718.46M	675.39M	676.74M	676.74M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	20.98M	17.75M	27.42M	27.42M
Operating expense	43.19M	50.34M	61.31M	61.31M
Total operating expenses	761.65M	725.72M	738.04M	738.04M
Operating income	68.46M	74.80M	92.75M	92.75M
Other non operating income	-1.56M	10.97M	-8.31M	-8.31M
EBT including unusual items	56.91M	57.22M	62.33M	62.33M
EBT excluding unusual items	56.91M	57.26M	61.57M	61.57M
Income tax expense	15.87M	14.57M	21.55M	21.55M
Effective tax rate	27.89%	25.46%	34.58%	34.58%
Other operating expenses	16.79M	27.03M	28.17M	28.17M
Net income	41.04M	42.65M	40.77M	40.77M
Net profit margin	4.94%	5.33%	4.91%	4.91%
Earnings per share	-	-	-	-
Interest and investment income	600.00K	-	2.38M	2.38M
Interest expense	-18.29M	-20.81M	-18.98M	-18.98M
Net interest expenses	-17.69M	-20.81M	-16.61M	-16.61M
Depreciation and amortization charges	5.42M	5.56M	5.72M	5.72M
EBITDA	72.35M	81.88M	95.30M	95.30M
Gain or loss from assets sale	-	-	44.50K	44.50K

Finance